CVLGNEIVMay 26, 2022

Acute Lymphoblastic Leukemia Detection Using Hypercomplex-Valued Convolutional Neural Networks

arXiv:2205.13273v126 citationsh-index: 21
Originality Incremental advance
AI Analysis

This work addresses the diagnosis of acute lymphoblastic leukemia, a type of blood cancer, by improving classification accuracy with more efficient models, though it appears incremental as it builds on existing hypercomplex methods.

The paper tackled the problem of detecting acute lymphoblastic leukemia by classifying lymphocytes in blood smear images using hypercomplex-valued convolutional neural networks, achieving an average accuracy of 96.6% with a simpler architecture and fewer parameters compared to real-valued models.

This paper features convolutional neural networks defined on hypercomplex algebras applied to classify lymphocytes in blood smear digital microscopic images. Such classification is helpful for the diagnosis of acute lymphoblast leukemia (ALL), a type of blood cancer. We perform the classification task using eight hypercomplex-valued convolutional neural networks (HvCNNs) along with real-valued convolutional networks. Our results show that HvCNNs perform better than the real-valued model, showcasing higher accuracy with a much smaller number of parameters. Moreover, we found that HvCNNs based on Clifford algebras processing HSV-encoded images attained the highest observed accuracies. Precisely, our HvCNN yielded an average accuracy rate of 96.6% using the ALL-IDB2 dataset with a 50% train-test split, a value extremely close to the state-of-the-art models but using a much simpler architecture with significantly fewer parameters.

Code Implementations1 repo
Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes